Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats

Neuropharmacology

Volumn 45, Issue 3, 2003, Pages 404-411

  Sokal, D M ^a   Elmes, S J R ^a   Kendall, D A ^a   Chapman, V ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cannabinoid 2 receptor; Peripheral anti nociception; Rat

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID RECEPTOR ANTAGONIST; CARRAGEENAN; HALOTHANE; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EVOKED AUDITORY RESPONSE; IN VIVO STUDY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD NERVE CELL;

EID: 0037966402     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00195-3     Document Type: Article

References (41)

1. Ahluwalia J., Urban L., Bevan S., Capogna M., Nagy I. Cannabinoid 1 receptors are expressed by nerve growth factor- and glial-cell-derived neurotrophic factor-responsive primary sensory neurones. Neuroscience. 110:2002;747-753.
2. Ahluwalia J., Yaqoob M., Urban L., Bevan S., Capogna M., Nagy I. Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem. 84:2003;585-591.
3. Calignano A., La Rana G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 394:1998;277-281.
4. Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24:2001;487-517.
5. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 53:1994;55-63.
6. Chapman V., Suzuki R., Dickenson A.H. Electrophysiological characterization of spinal neuronal response properties in anaesthetized rats after ligation of spinal nerves L5-L6. J. Physiol. 507:1998;881-894.
7. 2 cannabinoid receptors are implicated in inflammatory pain. Pain. 96:2002;253-261.
8. De Petrocellis L., Bisogno T., Davis J.B., Pertwee R.G., Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 483:2000;52-56.
9. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:(5090):1992;1946-1949.
10. Di Marzo V., Blumberg P.M., Szallasi A. Endovanilloid signalling in pain. Curr. Opin. Neurobiol. 12:2002;372-379.
11. 35S] GTPγS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rates. Eur. J. Neurosci. 12:2000;2079-2086.
12. Dubner R. Neural basis of persistent pain: sensory specialization, sensory modulation, and neuronal plasticity. Jensen T.S., Turner J.A., Wiesenfeld-Hallin Z. Proceedings of the Eighth World Congress on Pain, Progress in Pain Research and Management. vol. 8:1997;243-257 IASP Press, Seattle.
13. Ellington H.C., Cotter M.A., Cameron N.E., Ross R.A. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology. 42:2002;966-975.
14. Gauldie S.D., McQueen D.S., Pertwee R., Chessell I.P. Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br. J. Pharmacol. 132:2001;617-621.
15. Giuffrida A., Beltramo M., Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 298:2001;7-14.
16. 2, a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. 96:1999;14228-14233.
17. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
18. Hedo G., Laird J.M.A., Lopez-Garcia J.A. Time-course of spinal sensitization following carrageenan-induced inflammation in the young rat: a comparative electrophysiological and behavioural study in vitro and in vivo. Neuroscience. 92:1999;309-318.
19. Hohmann A.G., Herkenham M. Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience. 92:1999;1171-1175.
20. Iversen L., Chapman V. Cannabinoids: a real prospect for pain relief? Curr. Opin. Pharmacol. 2:2002;50-55.
21. Johanek L.M., Heitmiller D.R., Turner M., Nader N., Hodges J., Simone D.A. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain. 93:2001;303-315.
22. 2 cannabinoid receptor-mediated peripheral antinociception. Pain. 93:2001a;239-245.
23. 2 cannabinoid receptor agonist AM1241. American Society of Anesthesiologists Annual Meeting Abstracts A-894.
24. 2 cannabinoid receptors. Chem. Phys. Lipids. 121:2002;191-200.
25. Merril E.G., Ainsworth A. Glass-coated, platinum-plated tungsten microelectrodes. Med. Biol. Eng. Comput. 10:1972;662-672.
26. 2+ responses in adult rat dorsal root ganglion neurones. Br. J. Pharmacol. 135:2002;256.
27. 2 receptors. Pharmacol. Ther. 74:1997;129-180.
28. Pertwee R.G. Cannabinoid receptors and pain. Prog. Neurobiol. 63:2001;569-611.
29. Pertwee R.G., Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids. 66:2002;101-121.
30. Ralevic V., Kendall D.A., Jerman J.C., Middlemiss D.N., Smart D. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Eur. J. Pharmacol. 424:2001;211-219.
31. Richardson J.D., Aanonsen L., Hargreaves K.M. Antihyperalgesic effects of spinal cannabinoids. Eur. J. Pharmacol. 345:1998a;145-153.
32. 1 receptors. Pain. 75:1998;111-119.
33. Roberts L.A., Christie M.J., Connor M. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurones. Br. J. Pharmacol. 137:2002;421-428.
34. Ross R.A., Coutts A.A., McFarlane S.M., Anavi-Goffer S., Irving A.J., Pertwee R.G., MacEwan D.J., Scott R.H. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology. 40:2001a;221-232.
35. Ross R.A., Gibson T.M., Brockie H.C., Leslie M., Pashmi G., Craib S.J., Di Marzo V., Pertwee R.G. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol. 132:2001b;631-640.
36. Smart D., Gunthorpe M.J., Jerman J.C., Nasir S., Gray J., Muir A.I., Chambers J.K., Randall A.D., Davis J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129:2000;227-230.
37. Stanfa L.C., Sullivan A.F., Dickenson A.H. Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation. Pain. 50:1992;345-354.
38. Tognetto M., Amadesi S., Harrison S., Creminon C., Trevisani M., Carreras M., Matera M., Geppetti P., Bianchi A. Anandamide excites central terminals of dorsal root ganglion neurones via vanilloid receptor 1 activation. J. Neurosci. 15:2001;1104-1109.
39. Willougby K.A., Moore S.F., Martin B.R., Ellis E.F. The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282:1997;243-247.
40. Walker J.M., Huang S.M., Strangman N.M., Tsou K., Sandudo-Pena M.C. Pain modulation by release of the endogenous cannabinoid anandamide. Proc. Natl. Acad. Sci. 96:1999;12198-12203.
41. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.